Page last updated: 2024-10-25

dapsone and Urticaria

dapsone has been researched along with Urticaria in 40 studies

Urticaria: A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.

Research Excerpts

ExcerptRelevanceReference
"The appearance of bite cells associated with methemoglobinemia can be caused by oxidizing drugs such as dapsone in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency or high drug serum levels."8.12Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria. ( Awan, M; Brown, LE; Gandelman, JS; Geere, M; Hu, Y; Kogan, SC; Leavitt, AD; Pearson, HJ, 2022)
" Improvement in CSU was observed in 62 patients (78%) (36 [80%] with idiopathic and 26 [76%] with autoimmune disease) with dapsone."7.91Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria. ( Hoffmann, R; Liang, SE; Peterson, E; Soter, NA, 2019)
" With adequate monitoring, the use of dapsone in patients with pressure urticaria has such a good risk-benefit ratio that we support early treatment initiation."7.77Delayed pressure urticaria - dapsone heading for first-line therapy? ( Brehler, R; Grundmann, SA; Kiefer, S; Luger, TA, 2011)
"Dapsone (4,4'-diaminodiphenyl sulphone) is used for a variety of dermatological conditions including immunobullous diseases and urticarial vasculitis."7.72A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. ( Barker, TH; Gaffney, K; Garioch, JJ; Leslie, KS; Ridley, S; Ross, CN, 2003)
" We describe the clinical, serologic and immunogenetic data in a patient with manifestations of Sjögren's syndrome who developed urticarial vasculitis and photosensitive annular SCLE which were effectively treated with oral dapsone."7.68Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. ( Callen, JP; Holtman, JH; Klein, J; Neustadt, DH, 1990)
"Dapsone 100 mg daily led to a rapid and complete clearing of extensive vasculitic urticarial lesions in a female patient with systemic lupus erythematosus."7.66Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. ( Goerz, G; Ruzicka, T, 1981)
"A cases of systemic lupus erythematosus is reported, presenting with urticaria-like lesions and complement deficiencies, which was completely controlled by dapsone."7.66Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone. ( Matthews, CN; Saihan, EM; Warin, RP, 1978)
" The following drugs are undoubtedly effective and sometimes even the therapy of choice: tetracyclines in acne vulgaris and rosacea (including rosacea keratitis); penicillin G in acrodermatitis atrophicans and cold urticaria; dapsone in dermatitis herpetiformis and - as a powerful adjuvant - in acne vulgaris and rosacea."4.76[Positive side-effects of antibiotic and antimicrobial drugs in therapy (author's transl)]. ( Illig, L, 1979)
"The appearance of bite cells associated with methemoglobinemia can be caused by oxidizing drugs such as dapsone in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency or high drug serum levels."4.12Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria. ( Awan, M; Brown, LE; Gandelman, JS; Geere, M; Hu, Y; Kogan, SC; Leavitt, AD; Pearson, HJ, 2022)
" Improvement in CSU was observed in 62 patients (78%) (36 [80%] with idiopathic and 26 [76%] with autoimmune disease) with dapsone."3.91Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria. ( Hoffmann, R; Liang, SE; Peterson, E; Soter, NA, 2019)
" With adequate monitoring, the use of dapsone in patients with pressure urticaria has such a good risk-benefit ratio that we support early treatment initiation."3.77Delayed pressure urticaria - dapsone heading for first-line therapy? ( Brehler, R; Grundmann, SA; Kiefer, S; Luger, TA, 2011)
"Dapsone (4,4'-diaminodiphenyl sulphone) is used for a variety of dermatological conditions including immunobullous diseases and urticarial vasculitis."3.72A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. ( Barker, TH; Gaffney, K; Garioch, JJ; Leslie, KS; Ridley, S; Ross, CN, 2003)
" We describe the clinical, serologic and immunogenetic data in a patient with manifestations of Sjögren's syndrome who developed urticarial vasculitis and photosensitive annular SCLE which were effectively treated with oral dapsone."3.68Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. ( Callen, JP; Holtman, JH; Klein, J; Neustadt, DH, 1990)
"Dapsone 100 mg daily led to a rapid and complete clearing of extensive vasculitic urticarial lesions in a female patient with systemic lupus erythematosus."3.66Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. ( Goerz, G; Ruzicka, T, 1981)
"A cases of systemic lupus erythematosus is reported, presenting with urticaria-like lesions and complement deficiencies, which was completely controlled by dapsone."3.66Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone. ( Matthews, CN; Saihan, EM; Warin, RP, 1978)
"The first line treatment of urticaria still consists of non-sedating H1-antihistamines."2.42[New therapeutic strategies for the different subtypes of urticaria]. ( Kapp, A; Liekenbröcker, T; Raap, U; Wedi, B; Wieczorek, D, 2004)

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-199010 (25.00)18.7374
1990's6 (15.00)18.2507
2000's9 (22.50)29.6817
2010's12 (30.00)24.3611
2020's3 (7.50)2.80

Authors

AuthorsStudies
Bonnekoh, H1
Jelden-Thurm, J1
Butze, M1
Krause, K1
Maurer, M1
Kolkhir, P1
Hu, Y3
Geere, M3
Awan, M3
Leavitt, AD3
Brown, LE3
Pearson, HJ3
Gandelman, JS3
Kogan, SC3
Zheng, BQ1
Yan, YL1
Ou, M1
Wang, XH1
Holm, JG1
Ivyanskiy, I1
Thomsen, SF1
Takenaka, Y1
Ishiguro, N1
Kawashima, M1
Gusdorf, L1
Lipsker, D1
Cortés-Pinto, C1
Baradad Brusau, M1
Vilardell Vilellas, F1
Mascaró Galy, JM1
Arco Huguet, N1
Soria Gili, X1
Liang, SE1
Hoffmann, R1
Peterson, E1
Soter, NA1
Christiansen, J1
Kahn, R1
Schmidtchen, A1
Berggård, K1
Nath, PI1
Coop, CA1
Milkova, L1
Hallermann, C1
Simon, JC1
Treudler, R1
Seminario-Vidal, L1
Sami, N1
Miller, J1
Theos, A1
do Valle, SO1
França, AT1
Pires, GV1
Guimarães, P1
Dias, GA1
Levy, SA1
Grundmann, SA1
Kiefer, S1
Luger, TA1
Brehler, R1
Noda, S1
Asano, Y1
Sato, S1
Leslie, KS1
Gaffney, K1
Ross, CN1
Ridley, S1
Barker, TH1
Garioch, JJ1
Harthi, FA1
Kudwah, A1
Ajlan, A1
Nuaim, A1
Shehri, F1
Raap, U1
Liekenbröcker, T1
Wieczorek, D2
Kapp, A1
Wedi, B1
Cassano, N1
D'Argento, V1
Filotico, R1
Vena, GA1
Lee, JS1
Loh, TH1
Seow, SC1
Tan, SH1
Engin, B1
Ozdemir, M1
Criado, RF1
Criado, PR1
Martins, JE1
Valente, NY1
Michalany, NS1
Vasconcellos, C1
Parodi, A1
Nunzi, E1
Rebora, A1
Ruzicka, T1
Goerz, G1
Highet, AS1
Nürnberg, W1
Grabbe, J1
Czarnetzki, BM1
Valsecchi, R1
Rozzoni, M1
Sena, P1
Pansera, B1
Eiser, AR1
Singh, P1
Shanies, HM1
Boehm, I1
Bauer, R1
Bieber, T1
Cadnapaphornchai, MA1
Saulsbury, FT1
Norwood, VF1
Illig, L1
Matthews, CN1
Saihan, EM1
Warin, RP1
González Quijada, S1
López Lázaro, L1
Reinares García, L1
Borregón Carretero, SJ1
Sastre Varela, J1
Estrada Pérez, V1
Holtman, JH1
Neustadt, DH1
Klein, J1
Callen, JP1
Faulhaber, G1
Lechner, W1
Wozel, G1
Thiele, B1
Fortson, JS1
Zone, JJ1
Hammond, ME1
Groggel, GC1
Frucht, U1
Gramm, HJ1
Dennhardt, R1
Muramatsu, C1
Tanabe, E1

Reviews

4 reviews available for dapsone and Urticaria

ArticleYear
Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence.
    The Journal of dermatological treatment, 2018, Volume: 29, Issue:1

    Topics: Anti-Allergic Agents; Chronic Disease; Cyclosporine; Dapsone; Databases, Factual; Drug Resistance; H

2018
Neutrophilic urticarial dermatosis: A review.
    Annales de dermatologie et de venereologie, 2018, Volume: 145, Issue:12

    Topics: Arthralgia; Colchicine; Cryopyrin-Associated Periodic Syndromes; Dapsone; Dermis; Diagnosis, Differe

2018
[New therapeutic strategies for the different subtypes of urticaria].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:4

    Topics: Administration, Oral; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Autoimmunity;

2004
[Positive side-effects of antibiotic and antimicrobial drugs in therapy (author's transl)].
    Infection, 1979, Volume: 7 Suppl 6

    Topics: Acne Vulgaris; Acrodermatitis; Adolescent; Anti-Bacterial Agents; Child; Dapsone; Dermatitis Herpeti

1979

Trials

3 trials available for dapsone and Urticaria

ArticleYear
Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study.
    Acta dermato-venereologica, 2005, Volume: 85, Issue:3

    Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone

2005
Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:4

    Topics: Adolescent; Adult; Case-Control Studies; Dapsone; Female; Folic Acid Antagonists; Histamine H1 Antag

2008
Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features.
    The Journal of dermatological treatment, 2008, Volume: 19, Issue:2

    Topics: Acetates; Adult; Anti-Infective Agents; Chronic Disease; Colchicine; Cyclopropanes; Dapsone; Drug Th

2008

Other Studies

33 other studies available for dapsone and Urticaria

ArticleYear
In Urticarial Vasculitis, Long Disease Duration, High Symptom Burden, and High Need for Therapy Are Linked to Low Patient-Reported Quality of Life.
    The journal of allergy and clinical immunology. In practice, 2022, Volume: 10, Issue:10

    Topics: Adult; Colchicine; Dapsone; Female; Humans; Male; Middle Aged; Omalizumab; Patient Reported Outcome

2022
Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
    Hematology (Amsterdam, Netherlands), 2022, Volume: 27, Issue:1

    Topics: Dapsone; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Ur

2022
Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
    Hematology (Amsterdam, Netherlands), 2022, Volume: 27, Issue:1

    Topics: Dapsone; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Ur

2022
Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
    Hematology (Amsterdam, Netherlands), 2022, Volume: 27, Issue:1

    Topics: Dapsone; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Ur

2022
Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
    Hematology (Amsterdam, Netherlands), 2022, Volume: 27, Issue:1

    Topics: Dapsone; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Ur

2022
Successful treatment of acquired cutis laxa with urticarial eruption by diphenyl sulfone.
    Clinical and experimental dermatology, 2021, Volume: 46, Issue:3

    Topics: Adult; Cutis Laxa; Dapsone; Dermatologic Agents; Drug Administration Schedule; Female; Humans; Urtic

2021
Case of acquired cutis laxa with preceding urticarial eruption treated by diphenyl sulfone.
    The Journal of dermatology, 2018, Volume: 45, Issue:11

    Topics: Adult; Anetoderma; Dapsone; Female; Humans; Skin; Treatment Outcome; Urticaria

2018
Bullous pemphigoid in a 3-month-old infant after vaccination.
    Clinical and experimental dermatology, 2019, Volume: 44, Issue:3

    Topics: Anti-Infective Agents; Autoantibodies; Blister; Dapsone; Humans; Infant; Male; Pemphigoid, Bullous;

2019
Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria.
    JAMA dermatology, 2019, 01-01, Volume: 155, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Chronic Disea

2019
Idiopathic angioedema and urticarial vasculitis in a patient with a history of acquired haemophilia.
    Acta dermato-venereologica, 2015, Volume: 95, Issue:2

    Topics: Aged; Angioedema; Autoimmunity; Azathioprine; Colchicine; Dapsone; Drug Therapy, Combination; Hemoph

2015
Rash and a patch test result positive for cobalt in a patient with a hip replacement.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2014, Volume: 113, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Cetirizine; Cobalt; Dapsone

2014
Asymptomatic dapsone-induced agranulocytosis in a patient with chronic spontaneous urticaria.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2014, Volume: 12, Issue:8

    Topics: Aged; Agranulocytosis; Chronic Disease; Dapsone; Dose-Response Relationship, Drug; Granulocyte Colon

2014
Mycophenolate mofetil therapy for pediatric bullous pemphigoid.
    Dermatology online journal, 2015, Aug-15, Volume: 21, Issue:8

    Topics: Anti-Bacterial Agents; Clindamycin; Dapsone; Diagnosis, Differential; Drug Resistance; Humans; Immun

2015
Dapsone hypersensitivity syndrome during delayed pressure urticaria treatment.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2010, Volume: 104, Issue:2

    Topics: Adult; Dapsone; Dengue; Diagnosis, Differential; Drug Hypersensitivity; Erythema; Female; Fever; His

2010
Delayed pressure urticaria - dapsone heading for first-line therapy?
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2011, Volume: 9, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ascorbic Acid; Chronic Disease; Dapsone; Dose

2011
Long-term complete resolution of severe chronic idiopathic urticaria after dapsone treatment.
    The Journal of dermatology, 2012, Volume: 39, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone; Female; Humans; Middle Aged; Neut

2012
A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis.
    Clinical and experimental dermatology, 2003, Volume: 28, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Hypersensitivity; Female; Humans; Middle Aged

2003
Urticaria-like follicular mucinosis responding to dapsone.
    Acta dermato-venereologica, 2003, Volume: 83, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Face; Humans; Mucinosis, Follicular; Urticaria

2003
[Treating chronic urticaria].
    MMW Fortschritte der Medizin, 2006, Aug-03, Volume: 148, Issue:31-32

    Topics: Adrenal Cortex Hormones; Adult; Child; Chloroquine; Chronic Disease; Cyclosporine; Dapsone; Diagnosi

2006
Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis.
    Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; Blood Vessels; Colchicine; Daps

2007
Urticaria as presenting manifestation of pemphigus herpetiformis.
    Dermatologica, 1982, Volume: 164, Issue:4

    Topics: Administration, Topical; Adult; Aminopyrine; Anti-Inflammatory Agents; Dapsone; Female; Humans; Midd

1982
Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels.
    Dermatologica, 1981, Volume: 162, Issue:3

    Topics: Adult; Complement System Proteins; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Urticaria

1981
Urticarial vasculitis resembling systemic lupus erythematosus: efficacy of prednisone and dapsone combined.
    The British journal of dermatology, 1980, Volume: 102, Issue:3

    Topics: Adult; Dapsone; Diagnosis, Differential; Humans; Lupus Erythematosus, Systemic; Male; Prednisone; Ur

1980
Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline.
    Acta dermato-venereologica, 1995, Volume: 75, Issue:1

    Topics: Adult; Antigen-Antibody Complex; Complement C3; Dapsone; Drug Combinations; Drug Resistance; Female;

1995
Cold urticaria and delayed pressure urticaria in the same patient.
    Acta dermato-venereologica, 1996, Volume: 76, Issue:1

    Topics: Anti-Allergic Agents; Cold Temperature; Cyproheptadine; Dapsone; Female; Folic Acid Antagonists; Hum

1996
Sustained dapsone-induced remission of hypocomplementemic urticarial vasculitis--a case report.
    Angiology, 1997, Volume: 48, Issue:11

    Topics: Adult; Dapsone; Female; Humans; Skin; Urticaria; Vasculitis, Leukocytoclastic, Cutaneous

1997
Urticaria treated with dapsone.
    Allergy, 1999, Volume: 54, Issue:7

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone; Humans; Male; Urticaria

1999
Hypocomplementemic urticarial vasculitis: report of a pediatric case.
    Pediatric nephrology (Berlin, Germany), 2000, Volume: 14, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Child; Complement System Proteins; Dapsone; Fema

2000
Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone.
    The British journal of dermatology, 1978, Volume: 99, Issue:4

    Topics: Complement System Proteins; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Urt

1978
[Gastrointestinal involvement and the response to dapsone in a case of the urticarial vasculitis syndrome].
    Medicina clinica, 1991, Nov-23, Volume: 97, Issue:18

    Topics: Adult; Chronic Disease; Dapsone; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Human

1991
Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
    The Journal of rheumatology, 1990, Volume: 17, Issue:9

    Topics: Administration, Oral; Adult; Complement C2; Dapsone; Female; Humans; Lupus Erythematosus, Cutaneous;

1990
[Urticaria-vasculitis with bullous eruptions in visceral lupus erythematosus].
    Zeitschrift fur Hautkrankheiten, 1987, Jun-01, Volume: 62, Issue:11

    Topics: Adult; Antigen-Antibody Complex; Biopsy; Dapsone; Drug Therapy, Combination; Female; Fluorescent Ant

1987
[Urticaria vasculitis and sulfone, a case report].
    Zeitschrift fur Hautkrankheiten, 1987, Mar-01, Volume: 62, Issue:5

    Topics: Aged; Dapsone; Female; Humans; Urticaria; Vasculitis, Leukocytoclastic, Cutaneous

1987
Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone.
    Journal of the American Academy of Dermatology, 1986, Volume: 15, Issue:5 Pt 2

    Topics: Arthritis; Complement System Proteins; Dapsone; Female; Glomerulonephritis; Humans; Kidney Glomerulu

1986
[Toxic methemoglobinemia following the postoperative ingestion of 4,4-diaminodiphenylsulfone (DADPS)--on the differential diagnosis of cyanosis].
    Anasthesie, Intensivtherapie, Notfallmedizin, 1985, Volume: 20, Issue:1

    Topics: Adult; Cyanosis; Dapsone; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Me

1985
Urticarial vasculitis: response to dapsone and colchicine.
    Journal of the American Academy of Dermatology, 1985, Volume: 13, Issue:6

    Topics: Colchicine; Dapsone; Female; Humans; Middle Aged; Urticaria; Vasculitis

1985